Study Description

Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease, with 30-40% of patients failing to achieve complete responses to standard therapy... Show More

Study Accession Alternative Stable ID type
EGAS00001001025 Other

Publications

25723320